On the Pulse


The FDA recently issued a statement warning the public of the risks and potential false results obtained with noninvasive prenatal screening tests, noting that inappropriate usage and interpretation has resulted in improper medical decisions.

View Article

An integrated model for prenatal care that incorporates both virtual and in-person visits has been well-received by patients and health care providers alike, according to a review in the Journal of Midwifery & Women’s Health.

View Article

Prenatal attachment levels were enhanced among pregnant women who were pleased with their appearance and body, displayed a positive attitude about their physical fitness, and engaged in practices that bolstered their health and physical capacity, according to a study in the Journal of Obstetric, Gynecologic & Neonatal Nursing.

View Article

A study published in American Journal of Preventive Medicine compared prenatal care in women with various disabilities.

View Article

Because the treatment options for imminent extreme premature labor center largely on patient preference, decision aids (DA) can help facilitate the patient-provider discussion and guide the shared decision-making process.

View Article

An oral concurrent session at SMFM’s 42nd Annual Pregnancy Meeting highlighted an analysis of pregnancy outcomes after optimal prenatal opioid use disorder care.

View Article

An oral abstract presentation at SMFM’s 42nd Annual Pregnancy Meeting explored cfDNA testing and participants’ knowledge and willingness of genetic data sharing.

View Article

Through its new Visiting Scientist Program and Digital Innovation Fellowship, Maven aims to improve its care model and continue improving prenatal health outcomes.

View Article

Protocol 5 - In this protocol, Norton reviews the pathophysiology of fetal aneuploidy and the wide range of tests for it. Included are perspectives on cell-free DNA testing, first-trimester combined screening, nuchal translucency (NT) sonography, and pregnancy-associated plasma protein A (PAPP-A) and human chorionic gonadotropin (hCG), as well as quad marker screening in the second trimester in appropriate cases, and combined first- and second-trimester screening.

View Article

Recommendations for maternity care professionals based on MiPATH.

View Article